Clinical Trial Update: A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing nivolumab alone or with ipilimumab to placebo in localized renal cell carcinoma after partial nephrectomy; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Carcinoma, Renal Cell | Phase 3 | Status: COMPLETED | Results posted: 2024-12-18